Immunovant, Inc. (IMVT)
32.11
-1.14
(-3.43%)
USD |
NASDAQ |
Oct 06, 16:00
32.20
+0.09
(+0.28%)
After-Hours: 05:43
Immunovant Price : 32.11 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 33.51 | 33.51 | 31.36 | 32.11 | 1.674M |
| Oct 05, 2026 | 33.99 | 33.99 | 32.95 | 33.25 | 1.104M |
| Oct 02, 2026 | 34.11 | 34.24 | 33.21 | 33.62 | 1.022M |
| Oct 01, 2026 | 33.56 | 34.60 | 33.30 | 33.65 | 1.672M |
| Sep 30, 2026 | 33.62 | 34.20 | 33.12 | 33.78 | 1.434M |
| Sep 29, 2026 | 33.43 | 33.52 | 32.45 | 33.46 | 1.311M |
| Sep 28, 2026 | 32.93 | 33.77 | 32.65 | 33.49 | 1.229M |
| Sep 25, 2026 | 34.00 | 34.22 | 33.17 | 33.30 | 2.350M |
| Sep 24, 2026 | 34.21 | 34.54 | 33.35 | 34.00 | 1.480M |
| Sep 23, 2026 | 36.35 | 37.00 | 33.60 | 34.54 | 3.653M |
| Sep 22, 2026 | 37.38 | 38.15 | 36.84 | 37.29 | 2.255M |
| Sep 21, 2026 | 37.23 | 37.49 | 36.55 | 37.18 | 1.031M |
| Sep 18, 2026 | 37.52 | 38.35 | 36.80 | 36.95 | 2.944M |
| Sep 17, 2026 | 37.09 | 37.68 | 36.54 | 37.65 | 1.331M |
| Sep 16, 2026 | 36.75 | 37.22 | 36.11 | 36.38 | 1.169M |
| Sep 15, 2026 | 37.43 | 37.50 | 36.19 | 36.65 | 1.574M |
| Sep 14, 2026 | 37.25 | 38.03 | 37.00 | 37.66 | 1.111M |
| Sep 11, 2026 | 38.62 | 38.93 | 37.19 | 37.36 | 1.032M |
| Sep 10, 2026 | 38.18 | 38.30 | 37.52 | 38.10 | 1.083M |
| Sep 09, 2026 | 39.11 | 39.73 | 38.67 | 38.75 | 1.024M |
| Sep 08, 2026 | 38.59 | 40.56 | 38.34 | 39.57 | 1.514M |
| Sep 04, 2026 | 39.44 | 39.73 | 38.73 | 39.25 | 765743.0 |
| Sep 03, 2026 | 39.48 | 39.48 | 38.64 | 39.12 | 1.235M |
| Sep 02, 2026 | 40.15 | 40.96 | 38.61 | 39.49 | 1.331M |
| Sep 01, 2026 | 40.60 | 41.37 | 39.20 | 39.90 | 1.585M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roivant Sciences Ltd. | 35.53 |
| Moderna, Inc. | 187.46 |
| Altimmune, Inc. | 2.67 |
| Vertex Pharmaceuticals, Inc. | 502.31 |
| First Tracks Biotherapeutics, Inc. | 31.39 |
Price Related Metrics
| Price to Book Value | 9.006 |
| Earnings Yield | -8.75% |
| Market Cap | 6.623B |